According to Soligenix's latest financial reports the company's current EPS (TTM) is -$2.66. In 2022 the company made an earnings per share (EPS) of -$4.43 a decrease over its 2021 EPS that were of -$4.22.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.66 | -39.96% |
2022 | -$4.43 | 4.93% |
2021 | -$4.22 | -58% |
2020 | -$10.05 | 36.73% |
2019 | -$7.35 | -33.78% |
2018 | -$11.10 | -36.75% |
2017 | -$17.55 | 27.17% |
2016 | -$13.80 | -70.23% |
2015 | -$46.35 | -3.44% |
2014 | -$48.00 | -45.76% |
2013 | -$88.50 | 59.46% |
2012 | -$55.50 | 60.87% |
2011 | -$34.50 | -68.49% |
2010 | -$109.50 | -8.75% |
2009 | -$120.00 | 100% |
2008 | -$60.00 | -71.43% |
2007 | -$210.00 | -46.15% |
2006 | -$390.00 | 62.5% |
2005 | -$240.00 | -52.94% |
2004 | -$510.00 | -22.73% |
2003 | -$660.00 | -24.14% |
2002 | -$870.00 | -75.63% |
2001 | -$3,570 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $14.09 | -629.72% | ๐บ๐ธ USA |
Pfizer PFE | $1.86 | -169.95% | ๐บ๐ธ USA |
Sanofi SNY | $3.18 | -219.60% | ๐ซ๐ท France |
Onconova Therapeutics ONTX | -$1.00 | -62.39% | ๐บ๐ธ USA |
Athersys ATHX | -$3.03 | 13.95% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | -$2.00 | -24.78% | ๐ฎ๐ฑ Israel |
Emergent BioSolutions
EBS | -$12.08 | 354.31% | ๐บ๐ธ USA |